Variant report
Variant | esv3379178 |
---|---|
Chromosome Location | chr21:28188731-28191029 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:28181750..28184261-chr21:28187491..28189634,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9983638 | chr21:28188735-28188736 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370191305 | chr21:28188736-28188737 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs113920410 | chr21:28188737-28188738 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs457229 | chr21:28188739-28188740 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs62217268 | chr21:28188741-28188742 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs201166557 | chr21:28188743-28188744 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565367873 | chr21:28188765-28188766 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536591881 | chr21:28188824-28188825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531221496 | chr21:28188845-28188846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550828868 | chr21:28188860-28188861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369952164 | chr21:28189007-28189008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs468245 | chr21:28189029-28189030 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs529595927 | chr21:28189035-28189036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189430911 | chr21:28189047-28189048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566551844 | chr21:28189063-28189064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375617425 | chr21:28189071-28189072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370083451 | chr21:28189080-28189081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554215134 | chr21:28189225-28189226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200147770 | chr21:28189414-28189415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568991105 | chr21:28189473-28189474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538051449 | chr21:28189502-28189503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs117312465 | chr21:28189598-28189599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546479613 | chr21:28189624-28189625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568363377 | chr21:28189759-28189760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536605814 | chr21:28189791-28189792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376420506 | chr21:28189798-28189799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs55987960 | chr21:28189801-28189802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553452935 | chr21:28189816-28189817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs456604 | chr21:28189900-28189901 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs199765188 | chr21:28189961-28189962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114279615 | chr21:28190038-28190039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs182089518 | chr21:28190109-28190110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532702041 | chr21:28190123-28190124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186020771 | chr21:28190127-28190128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138728123 | chr21:28190168-28190169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550842951 | chr21:28190330-28190331 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561206821 | chr21:28190348-28190349 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375946937 | chr21:28190378-28190379 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562765672 | chr21:28190389-28190390 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs456954 | chr21:28190398-28190399 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs190778902 | chr21:28190415-28190416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs2011510 | chr21:28190432-28190433 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs532218995 | chr21:28190485-28190486 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369895971 | chr21:28190537-28190538 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141862386 | chr21:28190572-28190573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181148609 | chr21:28190584-28190585 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs461697 | chr21:28190597-28190598 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs186645147 | chr21:28190605-28190606 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534111975 | chr21:28190611-28190612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553318966 | chr21:28190640-28190641 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Alzheimer''s disease | 18923514 | CNVD |
Alzheimer''s disease | 20877625 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Alzheimer''s disease | 21956041 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 19212409 | CNVD |
Hypoplastic left heart syndrome | 22349727 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:28182600-28192200 | Weak transcription | NHEK | skin |
2 | chr21:28183800-28190200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr21:28187000-28192400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr21:28187400-28192600 | Weak transcription | Placenta | Placenta |
5 | chr21:28187600-28190200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr21:28188200-28188800 | Active TSS | HSMMtube | muscle |
7 | chr21:28188200-28192200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr21:28188400-28188800 | Enhancers | Osteobl | bone |
9 | chr21:28188400-28191800 | Weak transcription | Hela-S3 | cervix |
10 | chr21:28188400-28198600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
11 | chr21:28190200-28190400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr21:28190200-28190600 | Enhancers | Fetal Kidney | kidney |
13 | chr21:28190200-28190800 | Enhancers | Fetal Intestine Large | intestine |
14 | chr21:28190200-28191800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr21:28190200-28191800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr21:28190400-28191400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
17 | chr21:28190600-28191400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr21:28190600-28192000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
19 | chr21:28190800-28192400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
20 | chr21:28190800-28192600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
21 | chr21:28191000-28191800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |